Literature DB >> 495418

Rate of progression of severity of valvular aortic stenosis in the adult.

M D Cheitlin, E W Gertz, B H Brundage, C J Carlson, J A Quash, R S Bode.   

Abstract

In a retrospective study, 29 patients at least 20 years of age with known aortic stenosis are reported who had the peak systolic gradient (PSG) measured on at least two occasions without an intervening surgical procedure or episode of endocarditis. In these 29 patients, there were 31 intervals available for evaluation with a mean follow-up time of 43.5 months (1 week to 120 months). In 16 of the 31 intervals, the PSG increased by 50% or more and in 15, it did not. In the group where the PSG increased, the average rate of increase was 1.3 mm. Hg/month with the most rapid gradient increase at 3.8 mm. Hg/month. Progression to high gradient was correlated with the development of angina pectoris or left ventricular hypertrophy by voltage and ST-T wave changes. In this study, other symptoms were not helpful in predicting an increase in severity. It is still recommended, however, that any patient with aortic stenosis and the development of symptoms of congestive heart failure or exertional syncope should be suspected of having progressed to severe aortic stenosis and should be restudied.

Entities:  

Mesh:

Year:  1979        PMID: 495418     DOI: 10.1016/0002-8703(79)90465-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Rapid development of severe aortic stenosis from calcification of congenital bicuspid valve.

Authors:  N Brooks
Journal:  Br Med J       Date:  1980-08-09

2.  Efficient detection of aortic stenosis using morphological characteristics of cardiomechanical signals and heart rate variability parameters.

Authors:  Arash Shokouhmand; Nicole D Aranoff; Elissa Driggin; Philip Green; Negar Tavassolian
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

3.  Prognostic value of T1-mapping in TAVR patients: extra-cellular volume as a possible predictor for peri- and post-TAVR adverse events.

Authors:  Jonathan Nadjiri; Hanna Nieberler; Eva Hendrich; Albrecht Will; Costanza Pellegrini; Oliver Husser; Christian Hengstenberg; Andreas Greiser; Stefan Martinoff; Martin Hadamitzky
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-26       Impact factor: 2.357

4.  Percutaneous aortic balloon dilatation for calcific aortic stenosis in elderly patients: immediate haemodynamic results and short-term follow up.

Authors:  C Di Mario; K J Beatt; P de Feyter; M van den Brand; C E Essed; P W Serruys
Journal:  Br Heart J       Date:  1987-12

5.  Severe aortic stenosis in elderly patients.

Authors:  E Nylander; I Ekman; T Marklund; B Sinnerstad; E Karlsson; B Wranne
Journal:  Br Heart J       Date:  1986-05

6.  Measurement errors in serial echocardiographic assessments of aortic valve stenosis severity.

Authors:  Kalie Kebed; Deyu Sun; Karima Addetia; Victor Mor-Avi; Natasha Markuzon; Roberto M Lang
Journal:  Int J Cardiovasc Imaging       Date:  2019-12-21       Impact factor: 2.357

7.  Comparison of in-hospital outcomes between octogenarians and nonagenarians undergoing transcatheter aortic valve replacement: a propensity matched analysis.

Authors:  Rajkumar Doshi; Vaibhav Patel; Priyank Shah
Journal:  J Geriatr Cardiol       Date:  2018-02       Impact factor: 3.327

Review 8.  Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.

Authors:  Jie Yan; Ming Liu; Yu Zhang; Danning Yang; Fengshaung An
Journal:  Clin Cardiol       Date:  2022-08-28       Impact factor: 3.287

9.  The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers.

Authors:  Kumar Dharmarajan; Jill Foster; Megan Coylewright; Philip Green; John P Vavalle; Osman Faheem; Pei-Hsiu Huang; Amar Krishnaswamy; Vinod H Thourani; Lisa A McCoy; Tracy Y Wang
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.